| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311646 | Urology | 2005 | 6 Pages |
Abstract
The duration of the PSA response to treatment is significantly associated with length of survival for men with hormone-refractory metastatic prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Anthony V. D'Amico, Ming-Hui Chen, Michael C. Cox, William Dahut, William D. Figg,